Hostname: page-component-77f85d65b8-7lfxl Total loading time: 0 Render date: 2026-03-29T02:03:17.520Z Has data issue: false hasContentIssue false

Health Policy

Published online by Cambridge University Press:  06 February 2025

David Schmidtz*
Affiliation:
Presidential Chair of Moral Science, West Virginia University
Rights & Permissions [Opens in a new window]

Abstract

In clinical trials involving experimental subjects who are also patients, what is supposed to become of the imperative to focus on the patient’s best interest? A second set of policy questions concerns patients who want to die. Are there limits to the imperative to let patients choose for themselves? Is commodification a threat to autonomy? When, if ever, do costs and benefits become decisively important? Can we know what to count as a cost-effective preparation for the next pandemic? When we put procedures in place to protect against abuse, is there any way to prevent such measures from becoming bureaucratic obstacles to accomplishing anything at all?

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© 2025 Social Philosophy and Policy Foundation. Printed in the USA